These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 322921)

  • 101. Standardized stress and hypertension: comparison of effect of propranolol and methyldopa.
    Dunn FG; Melville DI; Jones JV; Lorimer AR; Lawrie TD
    Br J Clin Pharmacol; 1978 Mar; 5(3):223-6. PubMed ID: 656266
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Clinical pharmacology and pharmacokinetics of clonidine.
    Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
    Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Comparative 90-day toxicity of two decarboxylase inhibitors, benserazide and carbidopa, in the rat.
    Rauws AG; Vos JG; Garbis-Berkvens JM; Peters PW; de Vries T; van Logten MJ
    Toxicol Appl Pharmacol; 1982 Nov; 66(2):201-20. PubMed ID: 7164099
    [No Abstract]   [Full Text] [Related]  

  • 104. Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.
    Zavisca FG; Breau AP; Wurtman RJ
    Circ Res; 1979 Nov; 45(5):684-90. PubMed ID: 487531
    [TBL] [Abstract][Full Text] [Related]  

  • 105. L-alpha-methyl-dopa versus the racemic form--a comparative study of the hypotensive effect.
    Alestig K; Sannerstedt R
    Acta Med Scand; 1966 Jun; 179(6):747-53. PubMed ID: 5941328
    [No Abstract]   [Full Text] [Related]  

  • 106. Effects of alpha-methyldopa on blood pressure in the anaesthetized dog.
    Blower PR; Poyser RH; Robertson MI
    J Pharm Pharmacol; 1976 May; 28(5):437-40. PubMed ID: 6754
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Changes in plasma and extracellular fluid volume during long-term treatment with alpha-methyldopa in 11 thiazide-treated patients with essential hypertension.
    Leth A; Ibsen H
    Acta Med Scand; 1975; 198(1-2):45-8. PubMed ID: 1166823
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Cerebral decarboxylation of meta- and para-tyrosine.
    Boulton AA; Juorio AV
    Experientia; 1983 Feb; 39(2):130-4. PubMed ID: 6832285
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Alpha-methylDOPA dissociates hypertension, cardiovascular reactivity and emotional behavior in spontaneously hypertensive rats.
    LeDoux JE; Sakaguchi A; Reis DJ
    Brain Res; 1983 Jan; 259(1):69-76. PubMed ID: 6297668
    [No Abstract]   [Full Text] [Related]  

  • 110. PRESSOR RESPONSES TO NOXIOUS STIMULI IN HYPERTENSIVE PATIENTS: EFFECTS OF GUANETHIDINE SULFATE AND ALPHA METHYLDOPA.
    SHAPIRO AP; KRIFCHER E
    Circulation; 1964 Nov; 30():671-8. PubMed ID: 14230935
    [No Abstract]   [Full Text] [Related]  

  • 111. Effects of methyldopa on psychometric performance.
    Johnson B; Hoch K; Errichetti A; Johnson J
    J Clin Pharmacol; 1990 Dec; 30(12):1102-5. PubMed ID: 2273082
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients.
    Prescott LF; Buhs RP; Beattie JO; Speth OC; Trenner NR; Lasagna L
    Circulation; 1966 Aug; 34(2):308-21. PubMed ID: 5969361
    [No Abstract]   [Full Text] [Related]  

  • 113. Growth hormone and cortisol secretion after oral and intravenous administration of methyldopa.
    Syvälahti E; Seppälä PO; Iisalo E
    Acta Pharmacol Toxicol (Copenh); 1975 Sep; 37(3):257-64. PubMed ID: 1103571
    [No Abstract]   [Full Text] [Related]  

  • 114. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.
    Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT
    Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Central hypotensive effect of alpha-methyldopa.
    Henning M; van Zwieten PA
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:25. PubMed ID: 5630931
    [No Abstract]   [Full Text] [Related]  

  • 116. THE ACUTE HEMODYNAMIC EFFECTS OF L-ALPHA METHYLDOPA.
    VINCENT WA; KASHEMSANT U; CUDDY RP; SMULYAN H; EICH RH
    Am J Med Sci; 1963 Nov; 246():558-68. PubMed ID: 14082643
    [No Abstract]   [Full Text] [Related]  

  • 117. Effect of methyldopa on plasma renin activity in man.
    Mohammed S; Fasola AF; Privitera PJ; Lipicky RJ; Martz BL; Gaffney TE
    Circ Res; 1969 Nov; 25(5):543-8. PubMed ID: 4900604
    [No Abstract]   [Full Text] [Related]  

  • 118. Hypotensive activity of S-alpha-methyldopa during long-term (steady-state) intravenous infusions.
    Walson PD; Pesout J; Forsyth RP; Castagnoli N; Melmon KL
    J Pharmacokinet Biopharm; 1976 Oct; 4(5):389-94. PubMed ID: 826619
    [No Abstract]   [Full Text] [Related]  

  • 119. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 120. Incidence of a positive direct coombs test in patients on alpha-methyldopa.
    Carstairs KC; Breckenridge A; Dollery CT; Worlledge SM
    Lancet; 1966 Jul; 2(7455):133-5. PubMed ID: 4161378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.